mlsanityData to 14 Oct 2026

AI in Pharma for Personalized Sequential Decision-Making: Methods, Applications and Opportunities

arXiv 2311.18725 ↗First posted 30 Nov 2023stat.ME cs.LG stat.APcited by 0

Not on the map. Why?

Abstract (arXiv)

In the pharmaceutical industry, the use of artificial intelligence (AI) has seen consistent growth over the past decade. This rise is attributed to major advancements in statistical machine learning methodologies, computational capabilities and the increased availability of large datasets. AI techniques are applied throughout different stages of drug development, ranging from drug discovery to post-marketing benefit-risk assessment. Kolluri et al. provided a review of several case studies that span these stages, featuring key applications such as protein structure prediction, success probability estimation, subgroup identification, and AI-assisted clinical trial monitoring. From a regulatory standpoint, there was a notable uptick in submissions incorporating AI components in 2021. The most prevalent therapeutic areas leveraging AI were oncology (27%), psychiatry (15%), gastroenterology (12%), and neurology (11%). The paradigm of personalized or precision medicine has gained significant traction in recent research, partly due to advancements in AI techniques citehamburg2010path. This shift has had a transformative impact on the pharmaceutical industry. Departing from the traditional "one-size-fits-all" model, personalized medicine incorporates various individual factors, such as environmental conditions, lifestyle choices, and health histories, to formulate customized treatment plans. By utilizing sophisticated machine learning algorithms, clinicians and researchers are better equipped to make informed decisions in areas such as disease prevention, diagnosis, and treatment selection, thereby optimizing health outcomes for each individual.

Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 25 of its 74 references that are in the map. First posted on arXiv 30 Nov 2023.

Builds on

25 of 74 references.

References · 25

  1. 2018Off-Policy Deep Reinforcement Learning without Explorationcited by 1,241
  2. 2020Is Pessimism Provably Efficient for Offline RL?cited by 364
  3. 2021Bellman-consistent Pessimism for Offline Reinforcement Learningcited by 269
  4. 2021Pessimistic Model-based Offline Reinforcement Learning under Partial Coveragecited by 164
  5. 2015Multi-armed Bandit Models for the Optimal Design of Clinical Trials: Benefits and Challengescited by 114
  6. 2022A Review of Off-Policy Evaluation in Reinforcement Learningcited by 95
  7. 2018Confounding-Robust Policy Improvementcited by 76
  8. 2022Why So Pessimistic? Estimating Uncertainties for Offline RL through Ensembles, and Why Their Independence Matterscited by 76
  9. 2016Estimating Dynamic Treatment Regimes in Mobile Health Using V-learningcited by 65
  10. 2020Statistical Inference of the Value Function for Reinforcement Learning in Infinite Horizon Settingscited by 65
  11. 2020Semiparametric proximal causal inferencecited by 59
  12. 2018A confounding bridge approach for double negative control inference on causal effectscited by 36
13 more
  1. 2021A Minimax Learning Approach to Off-Policy Evaluation in Confounded Partially Observable Markov Decision Processescited by 36
  2. 2019On Multi-Armed Bandit Designs for Dose-Finding Clinical Trialscited by 32
  3. 2020Does the Markov Decision Process Fit the Data: Testing for the Markov Property in Sequential Decision Makingcited by 30
  4. 2021Estimating Optimal Infinite Horizon Dynamic Treatment Regimes via pT-Learningcited by 26
  5. 2018A Contextual-bandit-based Approach for Informed Decision-making in Clinical Trialscited by 18
  6. 2020Learning for Dose Allocation in Adaptive Clinical Trials with Safety Constraintscited by 13
  7. 2021Non-asymptotic Confidence Intervals of Off-policy Evaluation: Primal and Dual Boundscited by 11
  8. 2019Thompson Sampling for Contextual Bandit Problems with Auxiliary Safety Constraintscited by 10
  9. 2023Quasi-optimal Reinforcement Learning with Continuous Actionscited by 7
  10. 2020Multicategory Angle-based Learning for Estimating Optimal Dynamic Treatment Regimes with Censored Datacited by 5
  11. 2020Robust Q-learningcited by 5
  12. 2020Multi-stage optimal dynamic treatment regimes for survival outcomes with dependent censoringcited by 5
  13. 2021Improving the Performance of Bayesian Logistic Regression Model with Overdose Control in Oncology Dose-Finding Studiescited by 2

Built on by

Not cited yet.